Literature DB >> 9577392

Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures.

R Scott1, R Gregory, N Hines, C Carroll, N Hyman, V Papanasstasiou, C Leather, J Rowe, P Silburn, T Aziz.   

Abstract

Intellectual, psychological and functional outcomes were evaluated in a consecutive series of 20 Parkinsonian patients who had unilateral (UPVP) or simultaneous bilateral posteroventral pallidotomy (BPVP) using Image Fusion and Stereoplan (Radionics Inc., Boston, Mass., USA) with stimulation for lesion localization. Comprehensive baseline and 3-month postoperative neuropsychological and neurological assessment protocols were administered together with questionnaire measures of functional disability, quality of life and psychological symptomatology. Changes in patients' clinical presentation and scores on psychometric tests, questionnaires and observational rating scales were then examined. We observed no new neuropsychiatric sequelae directly related to pallidotomy. Cognitive sequelae were restricted to selective reductions in categorical verbal fluency following UPVP (P < 0.001) and BPVP (P < 0.01) and a reduction in phonemic verbal fluency following BPVP (P < 0.01); these changes were not reported subjectively. A fall in diadochokinetic rates (P < 0.01) and some subjective reports of a worsening in pre-existing dysarthria, hypophonia and hypersalivation/drooling following BPVP also suggested changes in speech motor apparatus; however, these changes did not have significant functional consequences. There was one case of more generalized cognitive impairment following BPVP. We also observed significant symptomatic improvement on neurological rating scales; following UPVP, Total Unified Parkinson's Disease Rating Scale (UPDRS) scores improved by 27% (P < 0.01) and following BPVP the improvement was 53% (P < 0.05). Patients' perceptions of reduced postoperative functional disability and improvements in 'quality of life' also achieved statistical significance on a number of both physical and psychosocial questionnaire subscales.

Entities:  

Mesh:

Year:  1998        PMID: 9577392     DOI: 10.1093/brain/121.4.659

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease.

Authors:  R J McCarter; N H Walton; A F Rowan; S S Gill; M Palomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

Review 2.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 3.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

Review 5.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

6.  Connectivity of the subthalamic nucleus and globus pallidus pars interna to regions within the speech network: a meta-analytic connectivity study.

Authors:  Jordan L Manes; Amy L Parkinson; Charles R Larson; Jeremy D Greenlee; Simon B Eickhoff; Daniel M Corcos; Donald A Robin
Journal:  Hum Brain Mapp       Date:  2013-11-25       Impact factor: 5.038

7.  Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation.

Authors:  M Merello; S Starkstein; M I Nouzeilles; G Kuzis; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

8.  Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease.

Authors:  A Daniele; A Albanese; M F Contarino; P Zinzi; A Barbier; F Gasparini; L M A Romito; A R Bentivoglio; M Scerrati
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

10.  Analysis of probabilistic classification learning in patients with Parkinson's disease before and after pallidotomy surgery.

Authors:  Jennifer R Sage; Stephan G Anagnostaras; Shawn Mitchell; Jeff M Bronstein; Antonio De Salles; Donna Masterman; Barbara J Knowlton
Journal:  Learn Mem       Date:  2003 May-Jun       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.